Jobs

Currently 617 Sales/Mktg jobs

Candidates Login

CV Database

Let the jobs come to you!

Company Login

Site Newsletter

Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

PharmiWeb on Facebook

Advertising

Press Releases

submit a press release

234 Press Releases

1 2 3 4 5 6 7 8

Date	Title	Company
24 May 13	Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
29 Apr 13	Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer	Teva Pharmaceutical Industries Ltd., Published by Business Wire
25 Apr 13	Teva Establishes Global Specialty Medicines Group	Teva Pharmaceutical Industries Ltd., Published by Business Wire
17 Apr 13	Teva Presented New Data from Phase III Clinical Trial of Milprosa™ (Progesterone) Vaginal Ring at the 61st Annual Meeting of the Pacific Coast Reproductive Society	Teva Pharmaceutical Industries Ltd., Published by Business Wire
10 Apr 13	Teva to Report First Quarter 2013 Financial Results on May 2, 2013	Teva Pharmaceutical Industries Ltd., Published by Business Wire
08 Apr 13	Teva-Handok Names Yoo Suk Hong as Chief Executive Officer	Teva Pharmaceutical Industries Ltd., Published by Business Wire
08 Apr 13	Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan	Teva Pharmaceutical Industries Ltd., Published by Business Wire
12 Mar 13	Teva to Present at the 2013 Barclays Global Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
09 Mar 13	Teva Files 2012 Annual Report on Form 20-F	Teva Pharmaceutical Industries Ltd., Published by Business Wire
01 Mar 13	Teva Calls 5.550% Senior Notes Due 2016 for Redemption	Teva Pharmaceutical Industries Ltd., Published by Business Wire
25 Feb 13	Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
22 Feb 13	Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting	Teva Pharmaceutical Industries Ltd., Published by Business Wire
14 Feb 13	Teva Announces FDA Approval of Generic Adderall XR®	Teva Pharmaceutical Industries Ltd., Published by Business Wire
11 Feb 13	Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors	Teva Pharmaceutical Industries Ltd., Published by Business Wire
07 Feb 13	Teva Reports Fourth Quarter and Full Year 2012 Results	Teva Pharmaceutical Industries Ltd., Published by Business Wire
05 Feb 13	Teva Announces First Patient Enrolled in Largest Clinical Study to Date Evaluating AZILECT® for Mild Cognitive Impairment in Parkinson's Disease	Teva Pharmaceutical Industries Ltd., Published by Business Wire
31 Jan 13	Teva Announces Termination of Agreements with CureTech	Teva Pharmaceutical Industries Ltd., Published by Business Wire
23 Jan 13	Teva Reports Top-Line Results from Second Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associated with Bipolar 1 Disorder	Teva Pharmaceutical Industries Ltd., Published by Business Wire
22 Jan 13	Teva to Report Fourth Quarter and Full Year 2012 Financial Results on February 7, 2013	Teva Pharmaceutical Industries Ltd., Published by Business Wire
07 Jan 13	Teva to Present at the 31st Annual J.P. Morgan Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
18 Dec 12	Teva Calls 1.700% Senior Notes Due 2014 for Redemption	Teva Pharmaceutical Industries Ltd., Published by Business Wire
18 Dec 12	Teva Signs New $3.0 Billion Syndicated Revolving Credit Facility	Teva Pharmaceutical Industries Ltd., Published by Business Wire
17 Dec 12	Teva Enters Agreement with Handok to Establish Business Venture with Significant Presence in Korean Pharmaceutical Market	Teva Pharmaceutical Industries Ltd., Published by Business Wire
11 Dec 12	Teva and Xenon Announce Teva’s World Wide License of Xenon’s Pain Drug XEN402	Teva Pharmaceutical Industries Ltd., Published by Business Wire
06 Dec 12	Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast	Teva Pharmaceutical Industries Ltd., Published by Business Wire
30 Nov 12	Teva Provides 2013 Non-GAAP Financial Outlook	Teva Pharmaceutical Industries Ltd., Published by Business Wire
30 Nov 12	Teva to Host Conference Call and Webcast on November 30, 2012	Teva Pharmaceutical Industries Ltd., Published by Business Wire
05 Nov 12	Teva Announces Changes to Executive Leadership Team	Teva Pharmaceutical Industries Ltd., Published by Business Wire
01 Nov 12	Teva Reports Third Quarter 2012 Results	Teva Pharmaceutical Industries Ltd., Published by Business Wire
26 Oct 12	Teva Receives Approval For SYNRIBOTM (Omacetaxine Mepesuccinate) for Injection	Teva Pharmaceutical Industries Ltd., Published by Business Wire

1 2 3 4 5 6 7 8

subscribe in a reader

Advertising

Share | | |

Site Map
Privacy & Security
Cookies
Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.